Skip to main content

Table 1 Demographic characteristics of subjects (N = 25)*

From: The immediate effect of individual manipulation techniques on pulmonary function measures in persons with chronic obstructive pulmonary disease

Variable Results Variable Results
Sex   Atrovent updraft  
Female 11 (44%) Yes 8 (35%)
Male 14 (56%) No 15 (65%)
Presently smoking   Type II DM  
Yes 9 (36%) Yes 4 (16%)
No 16 (64%) No 21 (84%)
Prior OMT   History of stroke  
Yes 21 (84%) Yes 2 (8%)
No 4 (16%) No 23 (92%)
Prior chiropractic treatment   History of heart failure  
Yes 22 (88%) Yes 2 (8%)
No 3 (12%) No 23 (92%)
Preference: OMT or chiropractic   History of thyroid disease  
OMT 11 (58%) Yes 3 (12%)
No preference 8 (42%) No 22 (88%)
Manipulation treatment for respiratory problem   History of pulmonary tuberculosis  
Yes 14 (56%) No 25 (100%)
No 11 (44%)   
Frequency of manipulative treatment   History of hypertension  
More than 1 per year 4 (16%) Yes 7 (28%)
One or less per year 21 (84%) No 18 (72%)
Oxygen use   History of coronary heart disease  
Yes 12 (50%) Yes 7 (28%)
No 12 (50%) No 18 (72%)
Theophylline use   History of pneumonia  
Yes 2 (8%) Yes 20 (80%)
No 22 (92%) No 5 (20%)
Inhaled steroid use   History of asthma  
Yes 10 (42%) Yes 11 (44%)
No 14 (58%) No 14 (56%)
Oral steroid use   History of cancer  
Yes 6 (26%) Yes 10 (40%)
No 17 (74%) No 15 (60%)
Inhaled bronchodilator   History of CABG  
Yes 18 (75%) Yes 2 (8%)
No 6 (25%) No 22 (92%)
Updraft treatments   History of lung surgery  
Yes 13 (52%) Yes 2 (8%)
No 12 (48%) No 23 (92%)
Atrovent MDI   Family history of lung disease  
Yes 14 (58%) Yes 13 (54%)
No 10 (42%) No 11 (46%)
  1. *Data are presented as number (% of subjects) for variables. Total counts may not add up to N due to missing values. All subjects were Caucasian.
  2. OMT, osteopathic manipulative treatment; MDI, metered-dose inhaler; DM, diabetes mellitus; CABG, coronary artery bypass graft.